Edoardo Crimini

Milan, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications

Oral selective estrogen receptor degraders (SERDs) for the treatment of hormone receptor-positive, HER2-negative breast cancer title.

Oral selective estrogen receptor degraders (SERDs) for the treatment of hormone receptor-positive, HER2-negative breast cancer title.

Journal: Expert opinion on pharmacotherapy
Published: May 22, 2026

Harnessing Vaccines in the Treatment of Solid Tumors: Advances, Challenges, and Future Directions.

Harnessing Vaccines in the Treatment of Solid Tumors: Advances, Challenges, and Future Directions.

Journal: Vaccines
Published: December 19, 2025

The role of the molecular tumor board: learnings from the ROME trial.

The role of the molecular tumor board: learnings from the ROME trial.

Journal: NPJ precision oncology
Published: November 18, 2025

Clinical outcomes of tumor-agnostic targeting of BRAF, tumor mutation burden-high, and RET.

Clinical outcomes of tumor-agnostic targeting of BRAF, tumor mutation burden-high, and RET.

Journal: ESMO open
Published: February 17, 2025

The Impact of Concordance between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the ROME Trial.

The Impact of Concordance between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the ROME Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 04, 2025

Molecular tumour board in gastrointestinal cancers.

Molecular tumour board in gastrointestinal cancers.

Journal: ESMO open
Published: January 21, 2025

Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial.

Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial.

Journal: Nature medicine
Published: December 27, 2024

The Safety and Suitability of DNA Sequencing of Tissue Biopsies Performed on Patients Referred to a Phase I Unit.

The Safety and Suitability of DNA Sequencing of Tissue Biopsies Performed on Patients Referred to a Phase I Unit.

Journal: Cancers
Published: October 10, 2024

Molecular tumor board in patients with metastatic breast cancer.

Molecular tumor board in patients with metastatic breast cancer.

Journal: Breast cancer research and treatment
Published: August 27, 2024

Genomic and clinical landscape of metastatic hormone receptors-positive breast cancers carrying ESR1 alterations.

Genomic and clinical landscape of metastatic hormone receptors-positive breast cancers carrying ESR1 alterations.

Journal: ESMO open
Published: June 12, 2024

Unfavorable carcinoma of unknown primary with a gastrointestinal profile: a retrospective study.

Unfavorable carcinoma of unknown primary with a gastrointestinal profile: a retrospective study.

Journal: ESMO open
Published: May 03, 2024

Deleterious alterations in homologous recombination repair genes and efficacy of platinum-based chemotherapy in biliary tract cancers.

Deleterious alterations in homologous recombination repair genes and efficacy of platinum-based chemotherapy in biliary tract cancers.

Journal: The oncologist
Published: January 09, 2024
Showing 1-12 of 43

Last Updated: 09/26/2026